Edmund Pezalla, M.D., MPH
National Medical Director for Pharmaceutical Policy and Strategy Aetna
Edmund Pezalla, M.D., MPH, is Aetna’s National Medical Director for Pharmaceutical Policy and Strategy. He is responsible for the integration of pharmacy policy and activities into Aetna’s overall strategy and operations. Dr. Pezalla also serves as the lead clinical spokesperson for Aetna in pharmacy related issues and represents Aetna on industry work groups and conferences.
Dr. Pezalla is Aetna’s leading expert on pharmaceutical development, reimbursement strategy and drug evaluation. He is active on projects with the IOM, CDC and FDA as well as MIT’s Center for Biomedical Innovation. Previously Dr. Pezalla was Chief Clinical Officer for Aetna Pharmacy Management from July 2007 to July 2010. In that role he was responsible for formulary development, quality and utilization programs and clinical strategy.
Dr. Pezalla has more than twenty years of experience in managed care and related areas. Prior to working at Aetna, he was vice president of clinical services for Prescription Solutions, a wholly-owned pharmacy benefits management subsidiary of United Health. Dr. Pezalla was also a health services research fellow and lecturer in pediatrics at the University of Michigan, and ran a consulting practice serving managed care firms.
Dr. Pezalla received his medical degree from Georgetown University and trained in general medicine and pediatrics at the Bethesda Naval Hospital. He also holds an MPH from the University of California at Berkeley and was a health services research fellow at the University of Michigan where he completed all but the dissertation in the doctoral program in Health Services Organization and Policy.
